Das Zentrum
Multiple Sklerose Zentrum Dresden
Patienteninformation
Kontaktinformation
Behandlungsteam
Studienteam
Neuropsychologie
Mobilitätszentrum
Das Mobilitätszentrum
Ganganalyse
Sprunganalyse
DIERS
EMIQ
Forschungsprojekte
Neuroimmunologisches Labor
Das NIL
Neurofilament-Leichtketten Analyse
Autonomes & Neuroendokrinologisches Funktionslabor
Das ANF
Untersuchungsmethoden
MS Living Lab
Management & Science
Team Management & Science
Projekte
eHealth & Analytics
MSDS 3D
MSDS Klinik & Praxis
MS-HRS
MTRS
MS Management
Aktuelles
Neuigkeiten
Publikationen
Veranstaltungen
Adventssymposium
MS Tag 2026
Multiple Sklerose 360°
Welt-MS-Tag 2021
Doktorarbeiten
Jobs
Kontakt
Spenden
Podcasts & Newsletter
Newsletter
Patienten-Podcast
Ärzte-Podcast
Neurovision
Digitalkalender 2026
Sherlock-MS-Blog
Studien
Interventionelle Studien
B-SHUTTLE
Nicht-interventionelle Studien
MS PATHS
Konectom
Sprachanalyse
Deutsch
Deutsch
English
A longitudinal analysis of real world symptom tracking and patient-reported outcomes in Brisa, a German Digital Health App for multiple sclerosis
MASC
Jahr
Publikationsjahr
2026
Autoren
Autorenliste der Publikation
Stratil AS, Papukchieva S, Steinmetz-Späh J, Joschko N, Masanneck L, Friedrich B, Ziemssen T.
Verlag
Publisher-Information
PLOS Digit Health. 2026 Oct 13;5(10):e0001751.
Link
Zur Publikation (externer Server)
https://doi.org/10.1371/journal.pdig.0001751
Tags
Forschungsthemen
Multiple Sklerose
MS Behandlung
Management & Science
eHealth
MSZ
MASC
eHealth
2026
User-centered design and formative evaluation of a gait dashboard for multidimensional walking assessment in multiple sclerosis
Mobility
Jahr
2026
Effects of Binge Drinking and Alcohol Withdrawal on Serum Neurofilament Levels
NIL
Jahr
2026
Delivering high-quality multiple sclerosis care in Germany: challenges and regional models
Multiple Sclerosis
Jahr
2026
MSPEECH (multiple sclerosis monitoring through speech interaction in clinic and at home): a Living Lab study protocol for co-created, speech-based digital biomarkers in multiple sclerosis
MASC
Jahr
2026
Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes
Multiple Sclerosis
Jahr
2026
